Teva Pharmaceutical shares have rebounded from lows, driven by debt reduction. Check out why I rate TEVA stock as Strong Buy.

Teva Pharmaceutical (NYSE:TEVA) announced that it will divest Teva-Takeda, its business venture in Japan, to JKI ...

Teva entered into an agreement with JKI Co., Ltd. (“JKI”) established by the fund managed and operated by private equity firm J-Will Partners ...

Shares in Teva Pharmaceutical Industries (NYSE: TEVA) closed more than 5% higher on Wednesday. The Israeli drugmaker earlier ...

Teva Pharmaceutical Industries has presented positive data from its Phase 3 SPACE study, demonstrating the efficacy and ...

Teva Pharmaceutical Industries has reported positive outcomes from its multicentre Phase III SPACE trial of Ajovy ...

Analyst evaluates Teva's stock performance and recommends holding due to revenue growth and successful debt reduction efforts ...

AstraZeneca appointed Iskra Reic as EVP of international to lead China operations after Leon Wang's suspension. Multiple companies shared updates: Janux announced $300M offering, Eli Lilly partnered ...

Teva (NYSE:TEVA) presented positive data from a Phase 3 study of its drug Ajovy in the prevention of episodic migraine in ...

Teva (TEVA) presented data from its Phase 3 SPACE study evaluating the efficacy and safety of Ajovy for the prevention of episodic migraine in ...

SPACE is a multicentre, randomised, double-blind, placebo-controlled, parallel-group study comparing the efficacy, safety, and tolerability of subcutaneous administration of fremanezumab versus ...

Teva Pharmaceutical Industries is trading at a lower price-to ... In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of ...